T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Apple
AAPL
|
+$4.53B |
| 2 |
Broadcom
AVGO
|
+$1.7B |
| 3 |
GE Vernova
GEV
|
+$1.29B |
| 4 |
International Paper
IP
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$956M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
NVIDIA
NVDA
|
+$2.09B |
| 3 |
Constellation Energy
CEG
|
+$1.9B |
| 4 |
Qualcomm
QCOM
|
+$1.84B |
| 5 |
Amazon
AMZN
|
+$1.56B |
Sector Composition
| 1 | Technology | 34% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Communication Services | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
The Bancorp
TBBK
$3.55B
| $33.9M | ﹤0.01% |
897,301
-291,848
| -25% | -$11M |
|
827
Tenable Holdings
TENB
$3.61B
| $33.5M | ﹤0.01% |
768,659
-130,085
| -14% | -$5.67M |
|
828
Endava
DAVA
$519M
| $33.5M | ﹤0.01% |
1,145,472
-3,289,672
| -74% | -$96.2M |
|
829
RadNet
RDNT
$5.78B
| $33.4M | ﹤0.01% |
566,156
+531,102
| +1,515% | +$31.3M |
|
830
DTE Energy
DTE
$28B
| $33.2M | ﹤0.01% |
298,955
+4,997
| +2% | +$555K |
|
831
Constellium
CSTM
$2.13B
| $33.1M | ﹤0.01% |
1,756,223
+57,323
| +3% | +$1.08M |
|
832
Chemed
CHE
$6.66B
| $33.1M | ﹤0.01% |
60,930
-2,803
| -4% | -$1.52M |
|
833
AngloGold Ashanti
AU
$32.6B
| $32.9M | ﹤0.01% |
+1,310,820
| New | +$32.9M |
|
834
Relay Therapeutics
RLAY
$705M
| $32.9M | ﹤0.01% |
5,039,015
-1,840,582
| -27% | -$12M |
|
835
Alpha Metallurgical Resources
AMR
$2.08B
| $32.8M | ﹤0.01% |
116,957
+8,861
| +8% | +$2.49M |
|
836
Beam Therapeutics
BEAM
$2.27B
| $32.7M | ﹤0.01% |
1,393,673
+147,484
| +12% | +$3.46M |
|
837
Day One Biopharmaceuticals
DAWN
$716M
| $32.4M | ﹤0.01% |
2,350,880
+51,116
| +2% | +$704K |
|
|
WRK
838
DELISTED
WestRock Company
WRK
| $32.1M | ﹤0.01% |
639,165
-1,265,209
| -66% | -$63.6M |
|
839
Nasdaq
NDAQ
$53.4B
| $32M | ﹤0.01% |
531,617
+14,617
| +3% | +$881K |
|
840
Federal Realty Investment Trust
FRT
$8.57B
| $32M | ﹤0.01% |
316,662
+7,559
| +2% | +$763K |
|
841
Blackbaud
BLKB
$3.35B
| $31.9M | ﹤0.01% |
418,648
+30,639
| +8% | +$2.33M |
|
|
CNTA
842
Centessa Pharmaceuticals
CNTA
$2.93B
| $31.9M | ﹤0.01% |
3,530,373
+572,294
| +19% | +$5.17M |
|
|
RAPP
843
Rapport Therapeutics
RAPP
$1.21B
| $31.6M | ﹤0.01% |
+1,360,605
| New | +$31.6M |
|
|
PWSC
844
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $30.8M | ﹤0.01% |
1,377,060
+162,828
| +13% | +$3.65M |
|
845
Prestige Consumer Healthcare
PBH
$3.14B
| $30.7M | ﹤0.01% |
445,910
+79,751
| +22% | +$5.49M |
|
846
Braze
BRZE
$3.55B
| $30.5M | ﹤0.01% |
786,250
+64,605
| +9% | +$2.51M |
|
847
Donnelley Financial Solutions
DFIN
$1.47B
| $30.5M | ﹤0.01% |
511,390
+182,726
| +56% | +$10.9M |
|
848
Landstar System
LSTR
$4.35B
| $30.4M | ﹤0.01% |
164,908
-116,464
| -41% | -$21.5M |
|
849
Apogee Therapeutics
APGE
$2.24B
| $30.2M | ﹤0.01% |
768,221
-402,106
| -34% | -$15.8M |
|
850
Crocs
CROX
$4.4B
| $30.1M | ﹤0.01% |
206,080
+2,649
| +1% | +$387K |
|